529 related articles for article (PubMed ID: 30791837)
1. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis?
Hatton G; Shawcross DL
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):1-2. PubMed ID: 30791837
[No Abstract] [Full Text] [Related]
2. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
4. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
Babickova J; Gardlik R
World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
[TBL] [Abstract][Full Text] [Related]
5. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications.
Ponziani FR; Gerardi V; Pecere S; D'Aversa F; Lopetuso L; Zocco MA; Pompili M; Gasbarrini A
World J Gastroenterol; 2015 Nov; 21(43):12322-33. PubMed ID: 26604640
[TBL] [Abstract][Full Text] [Related]
6. The Gut Microbiota in Celiac Disease and probiotics.
Chibbar R; Dieleman LA
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
[TBL] [Abstract][Full Text] [Related]
7. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
[TBL] [Abstract][Full Text] [Related]
8. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis.
Bajaj JS; Khoruts A
J Hepatol; 2020 May; 72(5):1003-1027. PubMed ID: 32004593
[TBL] [Abstract][Full Text] [Related]
9. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
10. Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer.
Stott KJ; Phillips B; Parry L; May S
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34236075
[TBL] [Abstract][Full Text] [Related]
11. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
12. Targeting Dysbiosis for the Treatment of Liver Disease.
Anand G; Zarrinpar A; Loomba R
Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
[TBL] [Abstract][Full Text] [Related]
13. Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure.
Jia Q; Li H; Zhou H; Zhang X; Zhang A; Xie Y; Li Y; Lv S; Zhang J
Cardiovasc Ther; 2019; 2019():5164298. PubMed ID: 31819762
[TBL] [Abstract][Full Text] [Related]
14. Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis.
Czaja AJ
World J Gastroenterol; 2016 Nov; 22(42):9257-9278. PubMed ID: 27895415
[TBL] [Abstract][Full Text] [Related]
15. The Intestinal Microbiome and the Liver Transplant Recipient: What We Know and What We Need to Know.
Doycheva I; Leise MD; Watt KD
Transplantation; 2016 Jan; 100(1):61-8. PubMed ID: 26647107
[TBL] [Abstract][Full Text] [Related]
16. The Link between Gut Microbiota and Hepatic Encephalopathy.
Won SM; Oh KK; Gupta H; Ganesan R; Sharma SP; Jeong JJ; Yoon SJ; Jeong MK; Min BH; Hyun JY; Park HJ; Eom JA; Lee SB; Cha MG; Kwon GH; Choi MR; Kim DJ; Suk KT
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012266
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
18. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
[TBL] [Abstract][Full Text] [Related]
19. GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons.
Katsi V; Didagelos M; Skevofilax S; Armenis I; Kartalis A; Vlachopoulos C; Karvounis H; Tousoulis D
Curr Hypertens Rev; 2019; 15(1):40-46. PubMed ID: 29895255
[TBL] [Abstract][Full Text] [Related]
20. Bacterial translocation in patients with liver cirrhosis: physiology, clinical consequences, and practical implications.
Ponziani FR; Zocco MA; Cerrito L; Gasbarrini A; Pompili M
Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):641-656. PubMed ID: 29806487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]